Previous Page  24 / 24
Information
Show Menu
Previous Page 24 / 24
Page Background

THE SIGNS & SYMPTOMS OF

COULD BE UNFOLDING IN FRONT OF YOU…

BUT WILL YOU SEE THEM IN TIME?

1-3

MPS I

OR

II

Left untreated, patients can face a reduced life expectancy

of as little as 10 years.

2,4

TREATMENTS ARE AVAILABLE,

SO DON’T DELAY. SUSPECT MPS TODAY.

If you suspect MPS I or II proceed to order a urinary metabolic screen

(including a urinary GAG test), or refer to your local metabolic physicians

for further information and advice.**

MPS: mucopolysaccharidosis; GAG: glycosaminoglycans. Images reproduced with permission.

References: 1.

Muenzer J

et al. Orphanet Journal of Rare Diseases

2017; 12: 82–91.

2.

Beck M

et al. Genet Med

2014; 16: 759–65.

3.

Burton B &

Giugliani R.

Eur J Pediatr

2012; 171: 631–9.

4.

Wraith J

et al. Genet Med

2008; 10: 508–16. Sanoˆ-aventis Australia Pty Ltd trading as Sanoˆ

Genzyme ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12–24 Talavera Road,

Macquarie Park, NSW 2113. GZANZ.ELAP.16.09.0171b(1)e. August 2017. AM7073.

Coarse facial features

**Aim to include as much clinical information as possible when requesting a metabolic screen.

*Exhibited by patients

with MPS I only.

3